Cargando…

Choroidal Blood Flow After Intravitreal Ranibizumab in Vitrectomized and Non-Vitrectomized Eyes with Diabetic Macular Edema

AIM: Diabetic retinopathy staging system and progression predictors are soon to be considered insufficient for ophthalmologic practice. Given the growing evidence of the role of choroidal dysfunction, our purpose was to assess choroidal vascular changes with intravitreal ranibizumab (RBZ) treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pessoa, Bernardete, Marques, João Heitor, Leite, João, Silva, Nisa, José, Diana, Coelho, Constança, Figueira, João, Meireles, Angelina, Melo-Beirão, João Nuno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519787/ https://www.ncbi.nlm.nih.gov/pubmed/34675476 http://dx.doi.org/10.2147/OPTH.S325037

Ejemplares similares

Vitrectomized versus non-vitrectomized eyes in diabetic macular edema response to ranibizumab—retinal layers thickness as prognostic biomarkers
por: Pessoa, Bernardete, et al.
Publicado: (2021)

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
por: Coelho, João, et al.
Publicado: (2019)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
por: Pessoa, Bernardete, et al.
Publicado: (2021)

Comparison of Intravitreal Dexamethasone Implant and Ranibizumab in Vitrectomized Eyes with Diabetic Macular Edema
por: Wang, Jia-Kang, et al.
Publicado: (2021)

Enzymatic vitreolysis for the treatment of tractional diabetic macular edema
por: Pessoa, Bernardete, et al.
Publicado: (2019)

Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex(®)) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema
por: Garlı, Murat, et al.
Publicado: (2021)

Challenging Clinical Cases – A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN(®))
por: Pessoa, Bernardete, et al.
Publicado: (2020)

Effectiveness of Intravitreal Ranibizumab in Nonvitrectomized and Vitrectomized Eyes with Diabetic Macular Edema: A Two-Year Retrospective Analysis
por: Gedar Totuk, Ozgun Melike, et al.
Publicado: (2020)

Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine–Gass Syndrome
por: Marques, João Heitor, et al.
Publicado: (2021)

Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes
por: Özdemir, Hüseyin Baran, et al.
Publicado: (2019)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
por: Tran, Thi Ha Chau, et al.
Publicado: (2021)

Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
por: Tran, Thi Ha Chau, et al.
Publicado: (2022)

Comparison of Inflammatory and Angiogenic Factors in the Aqueous Humor of Vitrectomized and Non-Vitrectomized Eyes in Diabetic Macular Edema Patients
por: Liang, Youling, et al.
Publicado: (2021)

Comparison of the Effect of Intravitreal Dexamethasone Implant in Vitrectomized and Nonvitrectomized Eyes for the Treatment of Diabetic Macular Edema
por: Çevik, Sadık Görkem, et al.
Publicado: (2018)

Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye
por: Aoki, Ren, et al.
Publicado: (2021)

Commentary: Treatment of postoperative cystoid macular edema in vitrectomized eyes: An enigma
por: Kohli, Piyush, et al.
Publicado: (2023)

Effect of Dexamethasone Implant on Subfoveal Choroidal Thickness in Early Period in Vitrectomized Eyes with Diabetic Macular Edema
por: Altun, A., et al.
Publicado: (2021)

Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
por: Maggio, Emilia, et al.
Publicado: (2022)

Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes
por: Freissinger, Sigrid, et al.
Publicado: (2020)

One-Month Outcomes of Intravitreal Anti-VEGF vs. Dexamethasone Implant in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes
por: Liang, Youling, et al.
Publicado: (2022)

Twelve-Month Follow-Up of Dexamethasone Implants for Macular Edema from Various Diseases in Vitrectomized and Nonvitrectomized Eyes
por: Novais, Eduardo A., et al.
Publicado: (2016)

Long-term management of non-ischemic central retinal vein occlusion with fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN®)
por: Coelho, João, et al.
Publicado: (2019)

Short-term Efficacy of Intravitreal Dexamethasone Implant in Vitrectomized Eyes with Recalcitrant Diabetic Macular Edema and Prior Anti-VEGF Therapy
por: Shah, Ankoor R., et al.
Publicado: (2016)

Office-based intravitreal injection of expansile gas for management of macular hole in previously vitrectomized eyes
por: Apolinario, Michael A., et al.
Publicado: (2019)

Dislocated Intraocular Lens Extraction and Iris-Claw Lens Implantation in Vitrectomized and Non-vitrectomized Eyes
por: Ersöz, M. Giray, et al.
Publicado: (2019)

Case of Spontaneous Closure and Recurrence of Macular Hole in Vitrectomized Eye
por: Komi, Yuki, et al.
Publicado: (2023)

Ocular biometry changes after mannitol administration in vitrectomized and non-vitrectomized eyes: A prospective, comparative study
por: Sahu, Abhipsa, et al.
Publicado: (2023)

Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg
por: Reibaldi, Michele, et al.
Publicado: (2012)

Macular hole developing in a post-vitrectomized eye and its surgical outcome
por: Rishi, Pukhraj, et al.
Publicado: (2013)

Ahmed Glaucoma Valve Implantation in Vitrectomized Eyes
por: Erçalık, Nimet Yeşim, et al.
Publicado: (2018)

Efficacy and safety of the dexamethasone implant in vitrectomized and nonvitrectomized eyes with diabetic macular edema: A systematic review and meta-analysis
por: Yuan, Qiongzhen, et al.
Publicado: (2022)

Intraocular Pharmacokinetics and Safety of Subretinal Injection Compared with Intravitreal Application of Conbercept in Vitrectomized Rabbit Eyes
por: Yao, Teng-teng, et al.
Publicado: (2020)

Positional Intraocular Pressure of Vitrectomized and Normal Fellow Eyes
por: Lee, Jae Hyuck, et al.
Publicado: (2018)

Descemet’s membrane endothelial keratoplasty in aphakic and vitrectomized eye
por: Karadag, Remzi, et al.
Publicado: (2020)

Two-Dimensional Cutting (TDC) Vitrectome: In Vitro Flow Assessment and Prospective Clinical Study Evaluating Core Vitrectomy Efficiency versus Standard Vitrectome
por: Pavlidis, Mitrofanis
Publicado: (2016)

Transient painful vision loss due to hypotony after an intravitreal injection in a previously vitrectomized eye
por: Alsoudi, Amer F., et al.
Publicado: (2022)

Managing Challenges of Phacoemulsification in Vitrectomized Eyes: A New Technique
por: Al Amro, Saleh A.
Publicado: (2020)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
por: Kim, Moosang, et al.
Publicado: (2013)

Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization
por: Figueira, João, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p007q1vkk8q648ig4cpi105q93